Physician profile
Neil M Badlani
NPI 1730344763
$71,470.68
in general payments reported to CMS, 2019-2025
19 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,429 · 2020: $3,073 · 2021: $1,363 · 2022: $52.15 · 2023: $3,523 · 2024: $43K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Honoraria: $17K · Travel and Lodging: $1,254 · Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,825.00 |
| Honoraria | $16,500.00 |
| Travel and Lodging | $1,254.37 |
| Food and Beverage | $974.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $32,000.00 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $30,213.44 | 2023-2025 | Kinevo 900, Opmi Pentero 800 |
| Medtronic USA, INC. | $6,057.54 | 2019-2020 | |
| Aegis Spine, INC. | $900.00 | 2021 | |
| Medtronic, INC. | $500.00 | 2023 | |
| Providence Medical Technology, INC. | $488.74 | 2024-2025 | |
| Si-Bone, INC. | $416.57 | 2019-2025 | |
| Relievant Medsystems, INC. | $196.05 | 2019-2020 | |
| Horizon Therapeutics Plc | $176.80 | 2019-2022 | |
| Cerapedics INC. | $169.20 | 2021-2024 | I-Factor Peptide Enhanced Bone Graft |
| Seaspine Orthopedics Corporation | $155.94 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $36.30 | 2022-2024 | Exparel, Iovera, Zilretta |
| Novapproach Spine, LLC | $36.24 | 2025 | Onelif |
| Vertex Pharmaceuticals Incorporated | $28.39 | 2024 | |
| Bioventus LLC | $26.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $22.52 | 2023 | |
| Fidia Pharma USA INC. | $18.06 | 2024 | Hymovis, Triluron, Hyalgan |
| Curonix LLC | $14.21 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Badlani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.